1MONDA L,WARNKE R,ROSAI J.A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation A report of 4 cases[J].Am J Pathol,1986,122:562-572.
2STORNIOLO A M,ALLERHEILIGEN S R,PEARCE H L.Preclinical,pharmacologic and phase I studies of Gemcitabine[J].Semin Oncol,1997,24(2 Suppl 7):S7-2-S7-7.
2Sung M T, Lopez-Beltran A, Eble J N, et al. Divergent pathway of intestinal metaplasia and cystitis Oanddads of the urinary bladder [J]. Mod Pathol, 2006,19( 11 ) : 1395-1401.
3Bryan R T, Nieholls J H, Harrison R F, et al. The role of beta-catenin signaling in the malignant potential of cystitis glandularis [J]. J Urol, 2003,170(5) : 1892-1896.
4Semins M J, Schoenberg M P. A case of florid cystitis glandularis [ J ]. Nat Clin Pract Urol, 2007,4(6) : 341-345.
6Pantuck A J, Bancila E, Das K M, et al. Adenocarcinoma of the urachus and bladder expresses a unique colonic epithelial epitope: an immunohistochemical study [J ]. J Urol, 1997,158 (5) : 1722-1727.
7De Berardinis E, Antonini G, Peters G J, et al. lntravesical administration of.gemcitabine in superficial bladder eancer:a phase I study with phamacodynamic evalution. BJU Int, 2004, 93(4) :491-494.
8Witjes J A, van der Heijden A G, Viesema J L, et al. Intravesical gemcitabine: a phase | and pharmacokinetic study [J]. Eur Urol, 2004,45(2) : 182-186.
9Dalbagni G, Russo P, Sheinfeld J, et al. Phase | trial of intravesical gemcitabine in bladder Calmette-Guerin-refractory transitional cell carcinoma of the bladder [J]. J Clin Oncol, 2002,20( 15 ) : 3193-3198.
10Lufer M, Ramalingam S, Schoenberg M P, et al. lntravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic study [J]. J Clin Oncol, 2003,21 (4) : 697-703.
